Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07601932 · ClinicalTrials.gov registry record · NA

Patient Positioning for Treatment of Proximal Ureteral Stones

A NA study, sponsored by Icahn School of Medicine at Mount Sinai.

Recruiting
Registry status
NA
Development phase
54
Enrollment target

NCT07601932 is a NA study that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 54 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07601932, a NA study, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.

RECRUITING
Registry status
NA
Development phase
54 participants
Enrollment target

Study Summary

Ureteroscopic management of proximal ureteral stones presents technical challenges including stone retropulsion, prolonged operative time, and conversion to intrarenal treatment. Reverse Trendelenburg positioning has been shown to reduce proximal stone migration and operative time in ureteral stones, while the T-tilt position improves intrarenal stone clearance. The optimal strategy for proximal ureteral stones (treating stones in situ using reverse Trendelenburg versus pushing stones into the kidney followed by intrarenal treatment in T-tilt) remains unknown. This randomized controlled trial compares these two strategies, with primary focus on operative time as a measure of procedural efficiency. A total of 54 patients (27 per arm) will be enrolled at Mount Sinai West.

Interventions

  • PROCEDURE Reverse Trendelenburg Position
  • PROCEDURE T-Tilt Position

Trial Details

FieldValue
Enrollment Target 54 participants
Start Date 2026-05-21
Est. Completion 2027-12
Phase NA

What the Registry Record Tells You About NCT07601932

The ClinicalTrials.gov registry entry for NCT07601932 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Reverse Trendelenburg Position is the first listed.

NCT07601932 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07601932 about?

NCT07601932 is a clinical study titled "Patient Positioning for Treatment of Proximal Ureteral Stones". Ureteroscopic management of proximal ureteral stones presents technical challenges including stone retropulsion, prolonged operative time, and conversion to intrarenal treatment. Reverse Trendelenburg positioning has been shown to reduce proximal stone migration and operative time in ureteral stones...

What is the current status of trial NCT07601932?

This trial is currently recruiting. It is a NA study. The enrollment target is 54 participants. The study started on 2026-05-21. Estimated completion is 2027-12.

What interventions are being tested in trial NCT07601932?

The interventions under investigation include: Reverse Trendelenburg Position (PROCEDURE), T-Tilt Position (PROCEDURE).

Who is sponsoring clinical trial NCT07601932?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.